The post Dr. Suzanne Cole on using real-world data to improve the generalizability of clinical trial results (highlights PrE1702 and EA5182) appeared first on ECOG-ACRIN Cancer Research Group.| ECOG-ACRIN Cancer Research Group
The post EA5181 trial finds no survival benefit for concurrent and consolidative durvalumab vs consolidation alone in unresectable non-small cell lung cancer appeared first on ECOG-ACRIN Cancer Research Group.| ECOG-ACRIN Cancer Research Group
Addison’s disease is no walk in the park. The disorder occurs when a person’s adrenal glands don’t make enough cortisol. This hormone plays a key role in multiple bodily functions, including metabolism and immune response. People with Addison’s disease can feel fatigued or nauseous, suffer from chronic pain, and lose unhealthy amounts of weight. If... The post Ever use cortisone? Thank one farmer and two CSHL scientists appeared first on Cold Spring Harbor Laboratory.| Cold Spring Harbor Laboratory
Breast cancer is one of the most common cancers among women in the United States, second only to skin cancer. Thanks to decades of fundamental research, it’s also one of the most curable. However, challenges remain, especially when confronting aggressive varieties like triple-negative breast cancer. Cold Spring Harbor Laboratory (CSHL) has a rich history of... The post Inspiring breast cancer breakthroughs appeared first on Cold Spring Harbor Laboratory.| Cold Spring Harbor Laboratory
Imagine your immune cells could be modified to attack any kind of cancer. T cell receptor (TCR) therapy has the potential to one day become a universal cancer treatment. But there are risks. Similarities between cancerous and healthy cells can affect the body’s immune response, causing T cells to attack unintended targets. TCR therapy needs... The post BATMAN brings TCR therapy out of the shadows appeared first on Cold Spring Harbor Laboratory.| Cold Spring Harbor Laboratory
Another Houston scientist has won one of the highly competitive National Science Foundation (NSF) CAREER Awards.| InnovationMap
Integrated cancer care center marks major milestone for patients seeking world-class cancer treatment The post Mayo Clinic Opens First Carbon Ion Therapy Center in the U.S. appeared first on Medical Travel Market.| Medical Travel Market
Cancer treatment is undergoing a paradigm shift with the emergence of FLASH radiotherapy (FLASH-RT). Developed by CERN and CHUV, this groundbreaking technique delivers ultra-high dose radiation in milliseconds. This approach holds the potential to revolutionize oncology by increasing tumor control while significantly reducing damage to healthy tissue. As FLASH-RT continues to evolve, companies such as […] The post FLASH Radiotherapy: A Revolutionary Advancement in Cancer Treatment appeared ...| Bold Business
AbbVie’s Elahere has been approved in the European Union as a treatment for adults with advanced, platinum-resistant ovarian cancer.| Rare Cancer News
May is Skin Cancer Awareness Month, a time to focus on the dangers of skin cancer and to promote early detection and prevention.| Ageless Living Cold Lake
In a small, rural town in southern Minnesota, Cyndi spent her days as a wife, mother and high school English teacher. In 2018, after she tried everything to mitigate persistent rib pain, she had an appointment that set her on a path she never anticipated.| Susan G. Komen®
📄6mins. A male with metastatic kidney cancer saw remarkable results using Fenbendazole after traditional treatments failed. Within months tumors disappeared, showcasing Fenbendazole's potential for advanced renal cell carcinoma.| Fenbendazole resource
Discover the potential of cryoablation as a less invasive cancer treatment option. Explore our complete guide to understanding this innovative therapy.| Vascular & Interventional Specialists of Prescott
Lowering the screening age, increasing health awareness and improving access to screening services can improve breast cancer outcomes for poor women.| The Wire Science
Many cancer treatments are designed to kill cancer cells. For the most part, they do a good job initially. But when cancer returns, the prevailing thought is that some cancer cells have eluded the treatment.| The Wire Science